ARIA Headlines | ARIAD Pharmaceuticals, Inc. Stock - Yahoo! Singapore Finance

Thu, 20 Jun 2013, 05:19 SGT - Singapore Markets open in 3 hrs 41 mins

STI

0.49%

More On ARIA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS

17.22 0.57(3.18%) 03:59 SGT|After Hours : 17.22 0.01 (0.06%) 04:00 SGT - Nasdaq Real Time Price

Add to Portfolio

Headlines

Get Headlines for:

Wednesday, June 19, 2013

ARIAD Honored with Gold Stevie® Awards as Pharmaceutical Company of the Year at 2013 American Business AwardsBusiness Wire (Wed, 19 Jun)
Ariad's Iclusig in GIST Phase II StudyZacks (Wed, 19 Jun)

Sunday, June 16, 2013

1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)at Motley Fool (Sun, 16 Jun)

Thursday, June 13, 2013

ARIAD Announces Webcast of Its Annual Shareholders MeetingBusiness Wire (Thu, 13 Jun)

Wednesday, June 12, 2013

Ariad Pharmaceuticals Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 02:40 PMat Seeking Alpha (Wed, 12 Jun)
4 Healthcare Stock Stories For Thursday Inspectionat Wall St. Cheat Sheet (Wed, 12 Jun)

Tuesday, June 11, 2013

Ash Stevens to Manufacture Ponatinib APIMarketwired (Tue, 11 Jun)
ARIAD Announces Initiation of Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal TumorsBusiness Wire (Tue, 11 Jun)
Ariad dips as analyst lowers lung cancer drug viewAP (Tue, 11 Jun)
Ariad dips as analyst lowers lung cancer drug viewAP (Tue, 11 Jun)

Saturday, June 8, 2013

Trader bets on floor under Ariad PharmaoptionMONSTER (Sat, 8 Jun)

Tuesday, June 4, 2013

ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, 4 Jun)
ARIAD to Present at Upcoming Investor ConferencesBusiness Wire (Tue, 4 Jun)
Why Ariad's Iclusig Is A Potential Blockbusterat Seeking Alpha (Tue, 4 Jun)
Ariad Pharmaceuticals Inc. - Shareholder/Analyst Callat Seeking Alpha (Tue, 4 Jun)

Monday, June 3, 2013

Scrappy Upstarts Aiming For Pfizer's Xalkori Marketat Seeking Alpha (Mon, 3 Jun)

Sunday, June 2, 2013

ARIAD Announces Long-Term Durability-of-Response Data on Ponatinib from Ongoing Phase 1 StudyBusiness Wire (Sun, 2 Jun)
ARIAD Presents Updated Phase 1 Data on AP26113 in Patients with Non-Small Cell Lung CancerBusiness Wire (Sun, 2 Jun)

Saturday, June 1, 2013

ARIAD Presents Analysis of Cardiovascular Risk Profile of Patients from Pivotal PACE Trial of Iclusig® (Ponatinib)Business Wire (Sat, 1 Jun)
ASCO Investment Ideasat Motley Fool (Sat, 1 Jun)

Older Headlines

Copyright © 2010 Yahoo! Southeast Asia Pte. Ltd. (Co. Reg. No. 199700735D). All Rights Reserved.

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.